Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- SHPH
- Price
- 3.80
- Stock movement up
- +0.07 (2.11%)
- Company name
- Shuttle Pharmaceuticals Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 3.62M
- Ent value
- 5.45M
- Price/Sales
- 187.41
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -93.37%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-09-15
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
SHPH does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 187.41 |
| Price to Book | - |
| EV to Sales | 282.29 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 1.07M |
| EPS (TTM) | -96.33 |
| FCF per share (TTM) | -59.96 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 19.31K |
| Gross profit (TTM) | 4.80K |
| Operating income (TTM) | -7.20M |
| Net income (TTM) | -9.19M |
| EPS (TTM) | -96.33 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 24.85% |
| Operating margin (TTM) | -37292.18% |
| Profit margin (TTM) | -47570.57% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 156.66K |
| Net receivables | 4.00 |
| Total current assets | 361.35K |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 312.22K |
| Total assets | 673.57K |
| Accounts payable | 1.35M |
| Short/Current long term debt | 564.26K |
| Total current liabilities | 1.66M |
| Total liabilities | 1.99M |
| Shareholder's equity | -1.32M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -5.70M |
| Capital expenditures (TTM) | 19.05K |
| Free cash flow (TTM) | -5.72M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -1363.91% |
| Return on Invested Capital | 912.55% |
| Cash Return on Invested Capital | 568.01% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 3.35 |
| Daily high | 3.49 |
| Daily low | 3.31 |
| Daily Volume | 10K |
| All-time high | 10480.00 |
| 1y analyst estimate | - |
| Beta | 0.42 |
| EPS (TTM) | -96.33 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SHPH | S&P500 | |
| Current price drop from All-time high | -99.97% | -1.46% |
| Highest price drop | -99.97% | -56.47% |
| Date of highest drop | 19 Aug 2025 | 9 Mar 2009 |
| Avg drop from high | -97.51% | -10.99% |
| Avg time to new high | 373 days | 12 days |
| Max time to new high | 745 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
3.62M
Marketcap category
Small-cap
Description
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Employees
9
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page